v3.24.3
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (unaudited) - USD ($)
 6 Months Ended
Oct. 31, 2024
Oct. 31, 2023
Cash flows from operating activities:    
Net income $ 126,599,000 $ 47,229,000
Adjustments to reconcile net income to net cash used in operating activities:    
Depreciation and amortization 39,266,000 38,566,000
Stock-based compensation expense 22,163,000 19,953,000
Provision for doubtful accounts 8,427,000 11,787,000
(Gain) loss on marketable securities (18,922,000) 1,024,000
Deferred income taxes 15,273,000 1,225,000
Gain on cash surrender value of life insurance policies (4,789,000) (3,947,000)
Impairment of right-of-use assets 0 1,629,000
Impairment of fixed assets 0 1,575,000
Change in other assets and liabilities:    
Accounts payable and accrued liabilities (214,832,000) (216,582,000)
Receivables due from clients (47,109,000) (34,394,000)
Deferred compensation 21,017,000 15,866,000
Unearned compensation (27,368,000) (14,807,000)
Income taxes and other receivables (14,078,000) (7,791,000)
Income taxes payable (12,471,000) 384,000
Prepaid expenses and other assets 1,511,000 (4,522,000)
Other 126,000 909,000
Net cash used in operating activities (105,187,000) (141,896,000)
Cash flows from investing activities:    
Purchase of property and equipment (24,807,000) (31,538,000)
Proceeds from sales/maturities of marketable securities 25,301,000 29,731,000
Purchase of marketable securities (23,892,000) (29,580,000)
Premium on company-owned life insurance policies (13,514,000) (251,000)
Proceeds from life insurance policies 612,000 9,332,000
Dividends received from unconsolidated subsidiaries 40,000 0
Net cash used in investing activities (36,260,000) (22,306,000)
Cash flows from financing activities:    
Repurchases of common stock (56,153,000) (9,527,000)
Dividends paid to shareholders (39,262,000) (19,289,000)
Payments of tax withholdings on restricted stock (16,984,000) (10,551,000)
Proceeds from issuance of common stock in connection with an employee stock purchase plan 4,248,000 4,696,000
Dividends - noncontrolling interest (1,570,000) (3,040,000)
Principal payments on finance leases (815,000) (938,000)
Payments on life insurance policy loans (519,000) 0
Net cash used in financing activities (111,055,000) (38,649,000)
Effect of exchange rate changes on cash and cash equivalents 6,347,000 (20,337,000)
Net decrease in cash and cash equivalents (246,155,000) (223,188,000)
Cash and cash equivalents at beginning of period 941,005,000 844,024,000
Cash and cash equivalents at end of the period $ 694,850,000 $ 620,836,000

Source

PDF